HeartWare International Inc. (NASDAQ:HTWR) closed a $143 million debt offering and announced the sale of $81.3 million worth of its stock by an investment firm.
The Framingham, Massachusetts-based cardiac assist firm said it sold $143.8 million worth of the convertible senior notes, including $18.8 million in an over-allotment purchased by underwriter J.P. Morgan Securities LLC. The notes will bear interest at 3.5 percent a year per annum and will mature Dec. 15, 2017.
HeartWare said it plans to use the proceeds from the offering for “expansion of its manufacturing capabilities and/or licensing of or investment in complementary products, technologies or businesses,” according to a press release.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Separately, major HeartWare investor Apple Tree Partners I LP closed a public offering of 1 million shares of HTWR stock at $81.31 per share, including 100,000 shares sold as an over-allotment.
HTWR shares were trading at $85.65 in mid-day activity, down 0.1 percent.
Despite increased losses, HeartWare’s third quarter sales almost doubled. The company reported a net loss of $7.8 million, or 57 cents per share, on sales of $13.8 million for the three months ended Sept. 30. That compares with net losses of $5.9 million, or 60 cents per share, on sales of $7.5 million during the same period last year.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
